Ylva Magnusson

2.0k total citations
28 papers, 1.6k citations indexed

About

Ylva Magnusson is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Spectroscopy. According to data from OpenAlex, Ylva Magnusson has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Spectroscopy. Recurrent topics in Ylva Magnusson's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Receptor Mechanisms and Signaling (7 papers) and Ion-surface interactions and analysis (5 papers). Ylva Magnusson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Receptor Mechanisms and Signaling (7 papers) and Ion-surface interactions and analysis (5 papers). Ylva Magnusson collaborates with scholars based in Sweden, France and United Kingdom. Ylva Magnusson's co-authors include Johan Hoebeke, Finn Waagstein, Å Hjalmarson, Gerd Wallukat, Göran Landberg, C.‐H. Bergh, L.-X. Fu, Jan‐Åke Liljeqvist, A. Donny Strosberg and S. Høyer and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Ylva Magnusson

28 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ylva Magnusson Sweden 17 669 620 292 144 133 28 1.6k
Eduardo Oliver Spain 20 569 0.9× 548 0.9× 148 0.5× 66 0.5× 83 0.6× 55 1.4k
Yoshino Matsuo Japan 24 735 1.1× 550 0.9× 266 0.9× 55 0.4× 213 1.6× 65 1.6k
Judith E. Kalinyak United States 24 786 1.2× 836 1.3× 468 1.6× 70 0.5× 102 0.8× 35 2.2k
Howard S. Silverman United States 27 1.8k 2.7× 1.2k 1.9× 177 0.6× 179 1.2× 142 1.1× 44 3.0k
Leonard S. Golfman Canada 18 1.3k 2.0× 808 1.3× 138 0.5× 51 0.4× 150 1.1× 26 2.3k
Shinichiro Iida Japan 20 581 0.9× 209 0.3× 143 0.5× 51 0.4× 301 2.3× 51 1.3k
Zhiwei Yang China 19 778 1.2× 270 0.4× 83 0.3× 63 0.4× 112 0.8× 40 1.3k
Shawn C. Black United States 20 1.1k 1.6× 417 0.7× 56 0.2× 96 0.7× 217 1.6× 46 2.0k
M. Koji Owada Japan 21 857 1.3× 302 0.5× 103 0.4× 52 0.4× 166 1.2× 43 1.8k
Hiroshi Ishizaka Japan 25 673 1.0× 614 1.0× 440 1.5× 27 0.2× 70 0.5× 83 2.1k

Countries citing papers authored by Ylva Magnusson

Since Specialization
Citations

This map shows the geographic impact of Ylva Magnusson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ylva Magnusson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ylva Magnusson more than expected).

Fields of papers citing papers by Ylva Magnusson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ylva Magnusson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ylva Magnusson. The network helps show where Ylva Magnusson may publish in the future.

Co-authorship network of co-authors of Ylva Magnusson

This figure shows the co-authorship network connecting the top 25 collaborators of Ylva Magnusson. A scholar is included among the top collaborators of Ylva Magnusson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ylva Magnusson. Ylva Magnusson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhost, Sara, Ylva Magnusson, Maria Ekholm, et al.. (2021). Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer. BMC Cancer. 21(1). 185–185. 9 indexed citations
2.
Walsh, Claire, Nina Akrap, Elena Garré, et al.. (2020). The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer. PLoS ONE. 15(7). e0236187–e0236187. 28 indexed citations
3.
Landberg, Göran, Emma Jonasson, Paul Fitzpatrick, et al.. (2020). Characterization of cell-free breast cancer patient-derived scaffolds using liquid chromatography-mass spectrometry/mass spectrometry data and RNA sequencing data. SHILAP Revista de lepidopterología. 31. 105860–105860. 6 indexed citations
4.
Rhost, Sara, Hannah Harrison, Pernilla Gregersson, et al.. (2018). Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion. Breast Cancer Research. 20(1). 137–137. 45 indexed citations
5.
Angerer, Tina B., Ylva Magnusson, Göran Landberg, & John S. Fletcher. (2016). Lipid Heterogeneity Resulting from Fatty Acid Processing in the Human Breast Cancer Microenvironment Identified by GCIB-ToF-SIMS Imaging. Analytical Chemistry. 88(23). 11946–11954. 65 indexed citations
6.
Tyo, Keith E. J., Zihe Liu, Ylva Magnusson, Dina Petranović, & Jens Nielsen. (2014). Impact of protein uptake and degradation on recombinant protein secretion in yeast. Applied Microbiology and Biotechnology. 98(16). 7149–7159. 27 indexed citations
7.
8.
Rossmeisl, Martin, Zuzana Macek Jílková, Ondřej Kuda, et al.. (2012). Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids. PLoS ONE. 7(6). e38834–e38834. 190 indexed citations
9.
Magnusson, Ylva, Peter Friberg, Peter Sjövall, et al.. (2008). Lipid imaging of human skeletal muscle using TOF‐SIMS with bismuth cluster ion as a primary ion source. Clinical Physiology and Functional Imaging. 28(3). 202–209. 31 indexed citations
10.
Magnusson, Ylva, Peter Friberg, Per Malmberg, & Yun Chen. (2008). Application of multivariate analysis of TOF-SIMS spectra for studying the effect of high glucose intake on aortic lipid profile. Applied Surface Science. 254(20). 6580–6585. 7 indexed citations
11.
Malmberg, Per, Håkan Nygren, Katrin Richter, et al.. (2007). Imaging of Lipids in Human Adipose Tissue by Cluster Ion TOF‐SIMS. Microscopy Research and Technique. 70(9). 828–835. 40 indexed citations
12.
Magnusson, Ylva, Malin Levin, Robert Eggertsen, et al.. (2005). Ser49Gly of β-adrenergic receptor is associated with effective β-blocker dose in dilated cardiomyopathy. Clinical Pharmacology & Therapeutics. 78(3). 221–231. 91 indexed citations
13.
Drvota, Viktor, et al.. (1999). The Effect of Amiodarone on the β-Adrenergic Receptor Is Due to a Downregulation of Receptor Protein and Not to a Receptor–Ligand Interaction. Biochemical and Biophysical Research Communications. 255(2). 515–520. 16 indexed citations
14.
Mobini, Reza, Ylva Magnusson, Gerd Wallukat, et al.. (1999). Probing the Immunological Properties of the Extracellular Domains of the Human β1-Adrenoceptor. Journal of Autoimmunity. 13(2). 179–186. 24 indexed citations
15.
Wallukat, Gerd, et al.. (1996). Agonistic effects of anti-peptide antibodies and autoantibodies directed against adrenergic and cholinergic receptors: absence of desensitization.. PubMed. 3. 31–6. 14 indexed citations
16.
Tate, K., Ylva Magnusson, M. Viguier, et al.. (1994). Epitope analysis of T- and B-cell response against the human β1-adrenoceptor. Biochimie. 76(2). 159–164. 14 indexed citations
17.
Wallukat, Gerd, Rosemarie Morwinski, Ylva Magnusson, Johan Hoebeke, & A Wollenberger. (1992). [Autoantibodies against the beta 1-adrenergic receptor in myocarditis and dilated cardiomyopathy: localization of two epitopes].. PubMed. 81 Suppl 4. 79–83. 9 indexed citations
18.
Lengagne, Renée, et al.. (1992). Induction of a pharmacologically active clonotypic B cell response directed to an immunogenic region of the human β2-adrenergic receptor. Clinical & Experimental Immunology. 89(3). 461–467. 8 indexed citations
19.
Magnusson, Ylva, Stéfano Marullo, S. Høyer, et al.. (1990). Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.. Journal of Clinical Investigation. 86(5). 1658–1663. 218 indexed citations
20.
Magnusson, Ylva, S. Høyer, Renée Lengagne, et al.. (1989). Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors.. PubMed. 78(1). 42–8. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo Oliver Breakdown of academic impact, for papers by Yoshino Matsuo Breakdown of academic impact, for papers by Judith E. Kalinyak Breakdown of academic impact, for papers by Howard S. Silverman Breakdown of academic impact, for papers by Leonard S. Golfman Breakdown of academic impact, for papers by Shinichiro Iida Breakdown of academic impact, for papers by Zhiwei Yang Breakdown of academic impact, for papers by Shawn C. Black Breakdown of academic impact, for papers by M. Koji Owada Breakdown of academic impact, for papers by Hiroshi Ishizaka
Rankless by CCL
2026